Venus Concept Receives FDA 510(k) Clearance of Venus BlissMAX
Venus Concept Inc announces it has received 510(k) clearance from the US Food and Drug Administration to market the Venus BlissMAX device in the United States.
Venus Concept Inc announces it has received 510(k) clearance from the US Food and Drug Administration to market the Venus BlissMAX device in the United States.
Findings suggest that tools designed to elicit patient values can improve communication and support African American women in choosing between implant-based and autologous reconstruction after mastectomy.